PF-562271, a specific inhibitor of FAK, was added into the medium after overexpressing Lasp1 in A549 (lung adenocarcinoma) and LK2 (squamous cell lung carcinoma) cells. The gene discussed is PTK2; the disease is squamous cell lung carcinoma.